Current Edition

news

AbbVie’s Botox wins reprieve as agency bars Evolus’ Jeaveau for alleged trade-secrets theft

AbbVie's aiming to make the most out of its new moneymaker Botox, gained in its Allergan megamerger last year, and it just scored a legal win—against ...
Continue Reading →
news

MacroGenics HER2 drug scores FDA breast cancer nod with Herceptin-topping data

MacroGenics’ oncology med Margenza is launching into the crowded HER2-positive breast cancer field. But the company has one advantage it can tout: The drug topped Ro...
Continue Reading →
news

Lilly and Regeneron COVID-19 antibodies are available all over the U.S. Why aren’t they getting to more patients?

About a month after the FDA issued emergency authorizations for COVID-19 antibodies from Eli Lilly and Regeneron, most of them have gone unused, a federal official s...
Continue Reading →
news

Biogen inks $22M charity kickbacks deal with feds, but argues its conduct was appropriate

Over the last few years, the federal government has inked charity kickback settlements with a who’s who of pharma companies. With a new Department of Justice settlem...
Continue Reading →
news

Fierce Pharma Asia—BioNTech-Fosun COVID-19 vax supply; Samsung Biologics’ new CEO; blank Avigan review

As BioNTech makes inroads with Pfizer for their COVID-19 vaccine in the Western world, the German biotech has agreed to supply 100 million doses for its Chinese...
Continue Reading →
news

FDA reviewers argue for Novartis ahead of Entresto advisory panel confab

Novartis’ Entresto chalked up a high-profile flop in a heart failure study last year, but the Swiss pharma shot for an FDA approval anyway. Now, reviewers at the age...
Continue Reading →
news

Lundbeck taps Mental Health America—and its big data—to create a national crisis dashboard

What if public health officials could track mental health crises as they happen? A new Mental Health America dashboard backed by Lundbeck looks to do just ...
Continue Reading →
news

Communication is the strong link in a supply-chain crisis

As the COVID-19 crisis began to take hold in the U.S. earlier this year, healthcare systems scrambled to treat critically ill patients in an unknown landscape. Tho...
Continue Reading →
news

AvKARE bottles mix Viagra generics with antidepressant, triggering recall

A generic drugmaker with a Rolodex full of federal clients is pulling an antidepressant and an erectile dysfunction med after the two were packaged together in the s...
Continue Reading →
Europe

Cerella is proven to accelerate drug discovery and increase confidence in lead optimisation

CAMBRIDGE, UK, 20 October 2020: Optibrium today announced the launch of Cerella, an Artificial Intelligence (AI) software platform for drug discovery that delivers a...
Continue Reading →